<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 215 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page214.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=215">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 215 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 215</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=215"><img src="../thumb/215.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>180 / 2020-04                                                        Gastro-Intestinal Tract - 12.4.4
   Adults incl.elderly: Act.duod.& benign gastr. ulc: 20 mg dly in   Dosage: Take once dly.oral dos.in the morn. Swall. whole. Admin.  Duod.ulc: 40 mg once dly. Use in combinat. with appropr.antibiot.
   morn.gener.4-6 wks. Addit.4-6 wks.may be requir. Some with act.  low.dos.& short.durat. appropr. to condit.treat.  when assoc.with H.Pylori.
   duod.ulc.may respond to 10 mg once dly.  Duod.ulc: 40 mg once dly. Tot.treatm.IV & oral should be 2-4 wks.   Gastr.ulc.& reflux oesophagit: 40 mg once dly.
   Eros./ulcerat.GORD: 20 mg once dly.x 4-8 wks. GORD maint: 10-  Use in combinat. with appropr.antibiot.when assoc.with H.Pylori.  Zolling.Ellison syndr: Init.80 mg/day, thereaft. titrat.up/down
   20 mg dly.for max.12 mnths. Symptomat.GORD: 10 mg once dly.in   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks. Tot.  accord.to gastric acid secret. Dly. dos. above 80 mg/day to be ad-
   pts.without oesophagit. Investig.furth.if control.not achiev. aft.4 wks.   treatm.IV & oral should be for 4-8 wks.  min.in 2 div.dos.
   Once sympts.resolv.admin.10 mg once dly.when necess.  Zollinger-Ellison syndr: Init.80 mg once dly. thereaft.titr.as necess.   If rapid acid contr.requir. a start.dos of 2 x 80 mg Prazoloc 40 IV is
   Zollinger-Ellison Syndr.& other patholog. hypersecret. con-  Admin.dly.dos.above 80 mg in 2 div.dos.  suffic.to manage a decr.of acid output into targ.range (&lt; 10 mEq/h)
   dits: Recomm.60 mg once dly. titrat.upwards to 120 mg/day bas.on in-  Mild GORD: 20 mg/day x4-8 wks.  within 1 hr in majority of pts.
   div.needs. Dos.upto 100 mg may be admin.as sngl.dly.dos. Dos. of 120   Long term/GORD relapse prevent: Recomm. maint: 20 mg/day   Contraindications: Sev.liv.funct.impairm., safety & effic.in childr.
   mg to be div.into 60 mg 2xdly. Contin. treatm. as long as clinic.indicat.  incr. to 40 mg/day in case of relapse reduc.to 20 mg dly aft.heal.  not est., concom.atazanavir & nelfinavir
   H.Pylori eradicat: Part of the eradicat.program. with appropr.antibiot.  NSAID induc.gastro-duod.les.& dyspept. sympts.prev:   Side effects: Freq: Asthen., fatig., diarrh.., headache. Less freq:
   Contraindications: Safety in pregn.& lactat.not est., no exper.  Recomm.dos: 20 mg once dly.   Agranulocytos., anaphylact. reacts.incl. angioed. & anaphylact.shock.,
   in use in childr.            Contraindications: Safety in pregn.& lactat.& safety & effic.in   anx., agitat., hallucin., somnol., arthralg., back/neck/ chest pain., blurr.
   Side effects: Headache, GI disturbs.incl.gastr. glandul.cyst, asthen.,   childr.not est., sev.liv.funct. impairm., concom.atazanavir., not for   vis., anter.ischaem.optic neuropathy, dizzin., speech disord., confus.,
   rash, dry mouth, infect., bld.dyscras., leucocytos., hypersens., anorex.,   mild GI compl.  hyperton., hypokines., migraine, paraesthes., dyspn., bronchit., incr.
   hypomagnesaem., hyponatraem., psych. disords. incl.confus., dizzin.,   Side effects: Bld.dyscras., blurr.vis., GI disturbs. incl.diarrh., asthen.,   cough., pharyngit., rhinit., sinusit., URTI, erythema multiforme, rash,
   somnol., vis.disturbs., periph. oed., cough, rhinit., pharyngit., bronchit.,   fatig., malaise, periph oed., sev.hepatocell.damage with jaund.with/  prurit., toxic epiderm.necrolys., Stev.-Johns.syndr., alopec., bullous
   sinusit., eruct., stomatit., hepatit., jaund., hepat. encephalopathy with   without hepat. fail./incr.liv.enzym., anaphylact.reacts. incl.shock/an-  erupts., hypoglycaem., impot., gynaecomast., infect., flu-like syndr.,
   underly.cirrhos., skin reacts. incl. erythema multiforme/tox.epiderm.  gioed., triglycerid.elev., incr. body temp., hyperlipidaem., arthralg.,   inj.site thrombophlebit., incr.sweat., malaise., N&V, abdom.pain,
   necrolys./ Stev. Johns.syndr., sweat., chest/non spec.back pain, my-  myalg., headache, dizzin., psych.disords., interstit.nephrit., sev.skin   constip., flatul., gastroenterit., pancreatit., belch., dyspeps., rect.dis-
   alg., leg cramps., arthralg., UTI, interstit. nephrit., chills, fev., gynae-  reacts. incl.erythema multiforme/Stev.Johns. syndr./ tox.epiderm.  ords., incr. salivat., taste disturbs., periph.oed., tinnit., vertigo, UTI,
   comast., flu-like syndr., weight gain, bone fract.  necrolys., photosens.  sev.hepatocellul. damage lead.to jaund.with/-out hepat.fail., incr.liv.
   Warnings and special precautions: Effic.for maint.treatm.of heal.  Special precautions: Elderly, ren.funct./ mild-mod. liv.impairm.,   enzym., hepatit., hepat. encephalopathy. Freq unknown: Allerg.re-
   eros./ulcer.GORD not est.for per.exceed. 12 mnths., pass.through rat   monit.concom.anticoag.ther., excl. poss.malign., confirm reflux oe-  acts. incl. skin rash & prurit., depress., insomn., dry mouth, incr.body
   placenta, excret.in rat mamar. secret., excl.malign.first, sev. hepat.dys-  sophag.diagn. by endoscopy, monit.liv.funct.in pres.of impairm.&   temp., elev.triglycerides, interstit. nephrit., myalg., thrombocytopen.,
   funct.esp. when init.ther., osteoporos.-relat.fract.of hip/wrist/spine   discont. if elev., poss.Vit.B12 malabsorpt.with prolong. treatm.(ie.&gt;3   leucopen., urticar., photosens.
   with high-dos./long-term ther., atazanavir co-admin.not recomm.,   yrs.), incr.Clostridium difficile risk, restrict.gastro duod.NSAID induc.  Warnings and special precautions: Not indicat. for mild GI
   poss. incr.GI infects. risk incl.Clostridium diffic., poss. methotrex. tox-  ulc. prophylax. to those at incr.risk.  complaints., not recomm.in pregn. & lactat.as safety & effic.not est.,
   ic., concom.ketoconazole/ itraconazole/ digoxin, concom.meds.poss.  Drug interactions: Poss.coagulat.fact.eff.with warfar., poss.chang.  with concom. anticoags.monit.prothromb.time/INH esp. when ther.
   caus. hypomagnesaem./ prolong.ther., discont.ther.& init.magnes.re-  in absorpt.of pH-depend. meds. eg. ketoconazole, reduc.atanavir   init./discont./admin.irreg., excl.poss. malign. as malign.ulc.sympt.
   placem.in hypomagnesaem.     bioavailab., poss.interacts.with meds.also metab.via cytochrome   poss.allev.delay. diagn., dos.not to exceed 20 mg dly in mild-mod.
   Drug interactions: Ser.lev.of concom. methotrex.poss.elev.& pro-  P450 enzyme syst.  liv. impairm., poss.cyanocobalam.malabsorpt.with prolong. treatm.
   long., ketoconazole/ itraconazole lev. decr., digoxin lev.incr., low   (ie.&gt;3 yrs.), discont.if liv.enzym. elev., confirm reflux oesophag.diagn.
   interact.potent.with ciclospor., reduc.atazanavir expos.with other   PEPLOC OTC, Pharma Dynamics [P/S]  by endoscopy, restrict to where contin.NSAID treatm.reqd.& incr. GI
   proton pump inhibit.         Pantoprazole.                 complicat.risk exist
                                                              Interactions: Atazanavir & nelfinavir conc.decr., poss. interacts.
                                Indications: Tempor.short-term heartburn & hyperacidity relief
   PENTOZ, Dr Reddy’s [P/S]     for max.14 days.              with other meds.metab.by hepat. cytochrome P450-enzyme syst.,
   Pantoprazole sodium sesquihydrate equiv.to pantoprazole  (S2) TABS, A43/11.4.3/0344  anticoag.respons. poss. affect., poss.changes in absorpt.of pH-de-
   Indications: 40 mg tabs: Short-term treatm.of duod./gastr. ulc.&   722787-001: 20 mg, 14, R41,83  pend. meds.eg.ketoconazole
   reflux oesophagit., duod.ulc. assoc.with H.pylori infect.in combinat.  Dosage: Take in the morn.
   with appropr. antibiot., Zollinger-Ellison syndr.  Recomm.dos: 20 mg/day  PRAZOLOC OTC, Cipla [P/S]
                                                              Pantoprazole.
   20 mg tabs: Mild gastro-oesophageal reflux dis. (GORD) & the long   Contraindications: Safety & effic.in childr.not est., sev.liv.funct.
   term managem.& relapse prevent. thereof.  impairm., concom.atazanavir.  Indications: Tempor.short-term heartburn & hyperacidity relief.
                                                              (S2) TABS, 43/11.4.3/1145
   (S4) TABS, 41/11.4.3/0641, 0642  Side effects: Bld.dyscras., anaphylact.reacts. incl. shock/angioed.,
   714674-001: 20 mg, 30, R123,28  incr.bilirub., triglycerid.elev., incr. body temp., hyperlipidaem., psych.  723826-001: 20 mg, 10, R31,24
                                                              Dosage: Take pref.in the morn. Swall.whole. Max.dly dos: 20 mg/
   714675-001: 40 mg, 30, R198,00  disords., headache, dizzin., blurr.vis., GI disturbs.incl. diarrh., dry
   Dosage: Admin.in morn.       mouth, sev.hepatocell.damage with jaund.with/without hepat.fail.,   day. Treatm.per: 14 days.
                                                              Contraindications: Safety & effic.in childr.not est., sev.liv.funct.
   Duod.ulc: 40 mg once dly. x2-4 wks. Use in combinat. with appropr.  prurit., skin rash, urticar., sev.skin reacts.eg.erythema multiforme/
   antibiot.when assoc.with H.Pylori.  Stev. Johns. syndr./tox.epiderm.necrolys., photosens., arthralg.,   impairm., concom. atazanavir/ nelfinavir.
                                                              Side effects: Dizzin., vis.disturbs., somnol., vertigo, GI disturbs.
   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.  myalg., hyponatraem., hypomagnesaem., interstit.nephrit., gynae-  incl.infects., bld.dyscras., anaphylact. reacts.incl. shock/angioed.,
   Zollinger-Ellison syndr: Init.80 mg dly.thereaft. titrat.as necess.   comast., asthen., fatig., malaise, periph oed.  triglycerid.elev., incr.body temp., psych./CNS disords., headache,
   Admin.dly.dos above 80 mg in 2 div.dos.  Warnings and special precautions: Safety in pregn.& lactat.not   paraesthes., anter.ischaem. opt. neuropathy, tinnit., periph.oed.,
   Mild GORD: 20 mg/day x4-8 wks.  est., monit.concom. anticoag. ther., excl.poss.malign., confirm reflux   dyspn., bronchosp., stomatit., sev.hepatocell.damage lead.to jaund.
   Long term/GORD relapse prevent: Recomm. maint: 20 mg/day   oesophag. diagn. by endoscopy, incr.Clostridium difficile risk, low.  with/without hepat.fail., incr.liv. enzym., hepat.encephalopathy, sev.
   incr. to 40 mg/day in case of relapse reduc.to 20 mg dly aft.heal. Long   dos.& short.durat.for condit., poss.assoc. hypomagnesaem.incr.risk of   skin reacts.incl. erythema multiforme/Stev.Johns.syndr./tox. epiderm.
   term.admin.exper.limit.      fract.of hip/wrist/ spine, monit.liv.funct.in pres.of impairm.& discont.   necrolys., photosens., arthralg., myalg., urin. syst.disords., interstit.
   (S2) OTC DELAY REL.TABS, 45/11.4.3/0592  if elev., do not use for mild GI complaints, poss. Vit.B12 malabsorpt.  nephrit., impot., gynaecomast., incr.sweat., malaise.
   Indications: Tempor.short term relief of heartburn & hyperacid.  with prolong.treatm.(ie.&gt;3 yrs.), Na restrict.diet,   Warnings and special precautions: Not indic. for mild GI compl.,
   718886-001: 20 mg, 7, R28,08  Drug interactions: Poss.coagulat.fact.eff.with warfar., poss.reduc./  excl.poss.malign., poss. Vit.B12 malabsorpt. with prolong.treatm.
   718886-002: 20 mg, 14, R56,17  incr.absorpt.of pH-depend. meds.eg. ketoconazole, reduc.atanavir   (ie.&gt;3 yrs.), discont. if liv.enzym.rise, confirm reflux oesophag. diagn.
   Dosage: Admin.bef./dur.breakf. Consult dr if no sympt.relief obt.  bioavailab., poss.interacts.with meds.also metab.via cytochrome   by endoscopy, safety & effic.in pregn.& lactat. not est., monit.con-
   within 2 wks.of continuous treatm.  P450 enzyme syst.      com.anticoag.ther., mild to mod.liv.impairm.
   Max.dos.20 mg/day for a max.of 14 days.                    Interactions: Decr.atazanavir/nelfinavir conc., poss. interacts.with
   Contraindications: Safety & effic.in childr.not est., sev.liv.funct.im-  PRAZOLOC, Cipla Medpro [P/S]  meds.also metab.via cytochrome P450 enzyme syst., poss.coagulat.
   pairm., safety in pregn.& lactat. not est., concom.atazanavir & nelfinavir.  Pantoprazole sodium sesquihydrate (equiv.to pantoprazole)  fact. eff.with warfar., poss.reduc./incr.absorpt.of pH-depend. meds.
   Side effects: Bld..dyscras., GI disturbs., allerg. reacts. incl.anaphy-  Indications: 20 mg tabs: Mild gastro-oesophag. reflux dis (GORD)   eg. ketoconazole.
   lax.& sev.skin reacts.eg.Stev. John.syndr./erythema multiforme/Ly-  & the long term managem.& relapse prevent.thereof, on-demand
   ell’s sndr., photosens., jaund.with/without hepat.fail., incr. body temp.,   regimen to control recurr.sympts.of heal.reflux dis., prevent.of   PROBITOR 20, (Unicorn) Sandoz [P/S]
   arthralg., myalg., headache, dizzin., blurr. vis., ment.depress., sleep   NSAID-induc.gastro-duod.les.& dyspept.sympt.in pts.at risk & need.   Omeprazole
   disords., hallucinat., confus., disorientat., interstit.nephrit.  contin.NSAID treatm.  Indications: Adults: Duod.ulc., gastr.ulc., reflux oesophagit.incl.
   Special precautions: Excl.poss.malign., not to exceed 20 mg dly   40 mg tabs: Short-term treatm.of duod.& gastr. ulc., reflux oe-  long-term managem., Zollinger-Ellison syndr., symptomat.heartburn
   in mild-mod.liv.impairm., monit. liv. funct.in sev.liv.impairm.partic.  sophagit., Zolling.-Ellison syndr.  rel. in gastro-oesophag.reflux dis., short-term rel.of funct. dyspeps.,
   with long term ther. & discont.if enzymes elev., not indicat.for mild   (S4) TABS, 43/11.4.3/1147, 1148  duod.ulc.assoc.with H.pylori infect.in combinat.with appropr.antibiot.,
   GI complaints, confirm reflux oesophag.diagn. by endoscopy, poss.  722767-001: 20 mg, 10, R31,24  NSAID assoc. gastric /duod.ulc.& reduc.risk of develop./relapse of
   cyanocobalam malabsorpt.with prolong.treatm. (ie.&gt;3 yrs.), contin.  722767-002: 20 mg, 30, R93,74  such assoc.ulc. Childr&gt;20 kg: Short term treatm. (upto 3 mnths) of
   self medicat.x4 wks./more to contr.sympts., incr.risk of bact.GI in-  722768-001: 40 mg, 30, R130,76  sev.ulcerat.reflux oesophagit.resist.to prev.treatm.
   fects., prothrombin time incr.,   Dosage: Admin.recomm.dos.in the morn.with/ without food.  (S4) CAPS, 43/11.4.3/0458
   Drug interactions: Reduc./incr.absorpt.of pH-depend. meds.eg.   Duod.ulc: 40 mg once dly.x2-4 wks. Use in combinat. with appropr.  720812-001: 20 mg, 28, R162,69
   ketoconazole/dasatinib/ampicill. esters/Fe salts/digox., atazanavir   antibiot.when assoc.with H.Pylori.  720812-002: 20 mg, 30, R174,31
   & nelfinavir plasma conc.decr., interacts with other meds. metabol.   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.  Dosage: Swallow whole in morn.
   by P450 enzyme syst.cannot be excl., incr. expos. to both meds.with   Zolling.Ellison syndr: Init.80 mg/day, thereaft. titrat.up/down   Adults:
   concom.voriconazole, diazepam & phenyt.eliminat.prolong.  accord.to gastric acid secret. Dly. dos. above 80 mg/day to be ad-  Duod.ulc: 20 mg dly.x2-4 wks. In pts.refract.to other treatm: 40
                                min.in 2 div.dos.
                                                              mg dly.may be effect.
   PEPLOC, Pharma Dynamics [P/S]  Mild GORD: 20 mg/day x4-8 wks. Recurr.sympt. contr. by 20 mg   Gastric ulc.& reflux oesophagit: 20 mg dly. x4-8 wks. When re-
   Pantoprazole.                once dly on demand.           fract.to other treatm.regimens 40 mg once dly.may be effect.
   Indications: 40 mg tabs: Short-term treatm.of duod. & gastr.ulc.,   Longt./GORD relapse prev: Recomm.maint. 20 mg/day incr.to   NSAID-assoc.gastroduod.les.with/without contin.NSAID
   reflux oesophagit., duod.ulc. assoc.with H.pylori infect.in combinat.  40 mg/day in case of relapse reduc.to 20 mg/day aft.heal.  treatm: 20 mg once dly.x4wks. If heal.not compl.contin.xfurth.4 wks.
   with appropr. antibiot., Zollinger-Ellison syndr.  NSAID induc.gastro-duod.les.& dyspeps. sympt: Recomm.  NSAID-assoc.gastroduod.les.& dyspept. sympt. prophylax:
   20 mg tabs: Mild gastro-oesophageal reflux dis (GORD) & the   dos.20 mg once dly.  20 mg once dly.
   longt.managem.& relapse prevent. thereof., prev.of NSAID induc.  (S4) SOL FOR INJ. 44/11.4.3/0305  Symptomat.gastro-oesophag.reflux dis: Indiv. 20 mg once dly.
   gastro-duod.les.& dyspept.sympts.in pts.at risk & need.cont.treatm.  Indications: Short-term treatm.of duod.& gastr. ulc./ reflux oe-  Investig.furth.if sympt.contr.not achiev.aft.2 wks.treatm.at 20 mg dly.
   (S4) TABS, [P/S] 42/11.4.3/0056, 42/11.4.3/0057.  sophagit./ Zolling.-Ellison syndr.in pts who cannot be treated orally  Zollinger-Ellison syndr: Init.60 mg dly. Indiv.& contin. as long as
   715306-001: 20 mg, 28, R71,88  720716-001: 40 mg/10 ml, 1 vial, R25,82  clinic.reqd. Admin.dos.over 80 mg dly.in 2 div.dos.
   715306-002: 20 mg, 30, R77,00  Dosage: For IV inj.only.    Childr.: (Limit.exper.)
   715307-001: 40 mg, 28, R184,81  Recomm.dos: 1 vial dly. for up to 7 days. Transit. to oral formulat.   Sev.ulcerat.reflux oesophagit: Childr.&gt;20 kg: 20 mg once dly.incr.
   715307-002: 40 mg, 30, R99,87  as soon as clinic.justif.   to 40 mg once dly.if necess.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page214.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page210.html">210</a>&nbsp;&nbsp;&nbsp;<a href="page211.html">211</a>&nbsp;&nbsp;&nbsp;<a href="page212.html">212</a>&nbsp;&nbsp;&nbsp;<a href="page213.html">213</a>&nbsp;&nbsp;&nbsp;<a href="page214.html">214</a>&nbsp;&nbsp;&nbsp;<a href="page215.html">215</a>&nbsp;&nbsp;&nbsp;<a href="page216.html">216</a>&nbsp;&nbsp;&nbsp;<a href="page217.html">217</a>&nbsp;&nbsp;&nbsp;<a href="page218.html">218</a>&nbsp;&nbsp;&nbsp;<a href="page219.html">219</a>&nbsp;&nbsp;&nbsp;<a href="page220.html">220</a>
             </td>
             <td width="35%"><a href="page216.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page216.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
